Targeted Paclitaxel Delivery to Tumors Using Cleavable PEG-Conjugated Solid Lipid Nanoparticles

Enzyme-responsive liposomes modified adenoviral vectors for enhanced tumor cell transduction and reduced immunogenicity

(2013) Yu Wan et al.   BIOMATERIALS

Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability

(2012) Ni Zeng et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway

(2012) S. Martins et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration

(2011) Rihua Li et al.   ARCHIVES OF PHARMACAL RESEARCH

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

(2011) Yuta Yoshizawa et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors

(2010) Ilia Rivkin et al.   BIOMATERIALS

Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging

(2010) Mathieu Goutayer et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

To PEGylate or not to PEGylate, that is not the question

(2010) Kinam Park   JOURNAL OF CONTROLLED RELEASE

Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting

(2010) Shyh-Dar Li et al.   JOURNAL OF CONTROLLED RELEASE

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer

(2009) Kai Xiao et al.   BIOMATERIALS

Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives

(2008) H XU et al.   JOURNAL OF CONTROLLED RELEASE

In Vitro and In Vivo Investigation on PLA–TPGS Nanoparticles for Controlled and Sustained Small Molecule Chemotherapy

(2008) Zhiping Zhang et al.   PHARMACEUTICAL RESEARCH